News
published at: 18.09.2024
New imaging procedures in cancer surgery: Helmholtz High Impact Award for Oliver Bruns and Ellen Sletten
18.09.2024: Biochemist Oliver Bruns (NCT/UCC Dresden) and chemist Ellen Sletten (UCLA) have been presented with the Helmholtz High Impact Award 2024 by the Helmholtz Association and the “Stifterverband für die Deutsche Wissenschaft” for their research into an innovative medical imaging technology in the short-wave infrared range. The procedure they have developed has the potential to significantly improve surgical removal of tumors. At yesterday’s award ceremony in Berlin, the two scientists were presented with the award – endowed with € 50,000 – in recognition of their interdisciplinary research.
published at: 30.08.2024
NCT/UCC Dresden: Millions in funding from the Chan Zuckerberg Initiative for state-of-the-art imaging to accurately detect minute tumors
30.08.2024: An international group of scientists led by Prof. Oliver Bruns (NCT/UCC Dresden), Dr. Andriy Chmyrov (NCT/UCC Dresden), Prof. Ellen Sletten (UCLA) and Prof. Christopher Rowlands (Imperial College London) has once again received renowned funding from the Chan Zuckerberg Initiative. With their research, the team strives to improve imaging in deeper tissue layers.
published at: 11.07.2024
Acute Myeloid Leukemia: Germany-wide clinical trial challenges international standard of care
published at: 11.07.2024
Acute myeloid leukemia: Longer time frame for decision-making when starting therapy
published at: 11.07.2024
„Custom-tailored to fit“ - NCT/UCC Dresden develops individualized cancer therapies
published at: 11.07.2024
Foundation stone laid for new building of the National Center for Tumor Diseases (NCT) Dresden
published at: 11.07.2024
Combination of active ingredients could improve chances of cure for ovarian cancer
published at: 11.07.2024